| Literature DB >> 30125508 |
Kyoung Sub Kim1, Dong Sup Kwag2, Hee Sook Hwang1, Eun Seong Lee2, You Han Bae1.
Abstract
We provide immense insulin absorption from the gastrointestinal tract, combining apical sodium-dependent bile acid transporter-mediated intestinal uptake and the lymphatic transport pathway. This strategy has proven to employ chondroitin sulfate- g-taurocholic acid coated, insulin-loaded partially uncapped liposome (IPUL-CST) for type 1 diabetes mellitus (T1DM) treatment. The loading efficiency of insulin in IPUL-CST increased significantly from 33% to 75% via the partially uncapped liposome preparation method. Moreover, the IPUL-CST revealed an improved insulin protection efficacy in GIT simulated pH and digestive enzyme conditions. The high dose of IPUL-CST in the small intestine was detected 4 h post-oral administration using ex vivo optical imaging and fluorescence intensity. The IPUL-CST exhibited significantly enhanced intestinal absorption (oral bioavailability, 34%; Tmax, 9 h) and reduced blood glucose levels for 16 h in T1DM. The results demonstrated that the new investigated IPUL-CST is a promising carrier for oral insulin delivery.Entities:
Keywords: chondroitin sulfate coated liposome; long acting insulin; massive intestinal absorption; oral insulin delivery; taurocholic acid
Mesh:
Substances:
Year: 2018 PMID: 30125508 PMCID: PMC6588159 DOI: 10.1021/acs.molpharmaceut.8b00708
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939